The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Mouse heart and blood cells obtained from reprogrammed skin cells

6 May 2008
Appeared in BioNews 456

Heart and blood cells can be grown from reprogrammed mouse skin cells, report University of California, Los Angeles (UCLA) researchers in the journal Stem Cells. The researchers say this is the first demonstration that stem cells from reprogrammed skin can be used to generate three types of heart and blood cell, including beating heart tissue. These could theoretically be used to repair damage following disease or heart attack.

Skin cells are transformed into stem cells using a combination of genetic factors. UCLA researchers were among those to develop the technique last June. The cells, known as induced pluripotent stem cells (iPS cells), resemble embryonic stem cells (ES cells) but do not require the use of human eggs or embryos in their development. A Canadian team previously generated beating heart tissue using embryonic stem cells.

Robb MacLellan and his team grew iPS cells on a protein matrix designed to promote the transition of stem cells into cardiovascular progenitors. These specialised cells were then treated under different conditions to direct development into three types of cardiovascular tissue: cardiomyocytes, or mature heart muscle cells that control heartbeat, endothelial cells, which form rudimentary blood vessels, and vascular smooth muscle cells, the specialized cells that line blood vessel walls. The cardiomyocytes began to beat once mature. 'I believe iPS cells address many of the shortcomings of human embryonic stem cells and are the future of regenerative medicine', said MacLellan, senior study author and associate professor of cardiology and physiology.

If iPS cell-derived cardiovascular tissues can be used to treat heart disease or damage, they could potentially allow personalised treatment following, for instance, a heart attack. A patient's own skin cells could provide iPS cells that in turn would be used to develop new heart tissue, which would be genetically matched to the patient thus avoiding immune rejection. 'Our hope is that, based on this work in mice, we can show that similar cardiovascular progenitor cells can be found in human iPS cells and, using a similar strategy, that we can isolate the progenitor cells and differentiate them into the cells types found in the human heart', MacLellan said.

Work is underway at UCLA to determine whether the techniques established in mice can be used in humans. Although human applications of this research remain distant, it seems that iPS cells could provide regenerative treatment in future without the need for the controversial use of human eggs and embryos.

Heart Cells Grown From Skin Cells?
WebMD |  30 April 2008
Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells
The Washington Post |  30 April 2008
New type of stem cells coaxed into heart tissue
Reuters |  30 April 2008
Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages
Stem Cells |  1 January 1970
23 March 2009 - by Ailsa Stevens 
The NHS Blood and Transplant Authority, the Scottish National Blood Transfusion Service and the Wellcome Trust have jointly announced a pioneering project to create a potentially unlimited supply of blood for transfusions using embryonic stem (ES) cells derived from surplus IVF embryos which are donated for research...
26 August 2008 - by Alison Cranage 
A team of scientists from the Advanced Cell Technology company (ATC), California, USA, have made massive amounts of red blood cells from human embryonic stem cells (ESC). The work may lead to laboratories being able to produce blood for transfusions, providing a limitless supply and an alternative...
2 June 2008 - by Dr Charlotte Maden 
Researchers at Johns Hopkins University School of Medicine in the US have found a faster and more efficient way to reprogramme cells into embryonic-like stem cells so that they can be used to study genetic disorders such as sickle cell anaemia. The study was published in the...
14 April 2008 - by Evelyn Harvey 
Nerve tissue derived from stem cells made from reprogrammed skin developed into normal brain tissue and relieved symptoms of Parkinson's disease in rats, in a study published in the journal Proceedings of the National Academy of Sciences of the USA (PNAS) last week. Scientists at the Whitehead...
19 February 2008 - by MacKenna Roberts 
Japanese researchers announced last week that they have advanced their understanding and ability to safely 'reprogramme' adult stem cells to resemble embryonic stem (ES) cells without inducing tumours or harmful genetic abnormalities. The Japanese team of researchers, lead by Dr Shinya Yamanaka at Kyoto University, reprogrammed liver...
21 January 2008 - by MacKenna Roberts 
Scientists at the California biotechnology company, Stemagen, announced last week that they had successfully cloned the world's first human embryos, created from adult male skin cells. Although British scientists cloned human embryos two years ago, this is the first time that scientists have managed to grow such...
14 January 2008 - by Katy Sinclair 
The Japanese scientist whose team was responsible for the breakthrough that enabled human skin cells to be reprogrammed to behave like stem cells, Shinya Yamanaka from Kyoto University, has estimated that stem cell treatments for some diseases could be as little as a decade away. Stem cells...
26 November 2007 - by Dr Jess Buxton 
Two groups of scientists have managed to 'reprogramme' skin cells, retuning them to an embryonic-like state in which they regain the potential to develop into any type of body cell. The studies, published in the journals Cell and Science, pave the way for new research aimed...
11 June 2007 - by Ailsa Stevens 
By Ailsa Taylor: Three independent research groups have reported successfully causing skin cells from adult mice to revert back to an embryonic stem cell-like state; a technique that could potentially help to resolve the ongoing ethical debate over stem cell research. Published in the journal Nature, this groundbreaking research could...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.